Sentinel node–guided radiotherapy in Japanese patients with early-stage breast cancer: a single-institution experience with partial-breast brachytherapy and regional nodal irradiation
Japanese Journal of Clinical Oncology · 2025
DOI: 10.1093/jjco/hyaf133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Japanese Journal of Clinical Oncology, 2025. Verfasst von Kazuhiko Sato und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Oncology, Tokyo-West Tokushukai Hospital, 3-1-1 Matsubara, Akishima, Tokyo 196-0003, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms, Brachytherapy, Sentinel Lymph Node, Radiotherapy, Image-Guided. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Introduction
Breast-conserving therapy involves breast-conserving surgery (BCS) with sentinel node (SN) biopsy, followed by whole-breast irradiation (WBI). As a de-escalating strategy, partial-breast irradiation (PBI) has been implemented in SN-negative patients. In contrast, postoperative WBI with regional nodal irradiation (RNI) has replaced axillary clearance in SN-positive patients. This study evaluates the oncological outcomes of these SN-based strategies in Japanese patients. Patients and methods This retrospective study included clinical node-negative patients who underwent BCS with SN biopsy between January 2016 and November 2024. Perioperative PBI using multicatheter interstitial brachytherapy (MIB) was administered to patients with pN0(sn) or pN1mi(sn) disease, whereas WBI with RNI was administered to those with pN+(sn) disease. Oncological outcomes were assessed based on locoregional recurrence (LRR), distant recurrence (DR), and overall survival (OS).
Results
Among 828 patients, 694 (83.8%) received MIB-PBI and 134 (16.2%) underwent WBI alone. Based on SN status, 649 (78.4%) patients received MIB-PBI, 114 (13.8%) underwent WBI alone, and 65 (7.8%) underwent WBI with RNI. After a median follow-up of 54 months, there was no significant difference in 5-year LRR-free survival (97.5% vs 97.1% vs 97.0%; p = 0.78); however, significant differences were observed in DR-free (99.6% vs 98.4% vs 93.6%; p < 0.001) and OS (99.4% vs 98.4% vs 93.6%; p < 0.001) among the MIB-PBI, WBI alone, and WBI with RNI groups, respectively.
Discussion
Despite the limitations of a retrospective design, a small sample size, and a relatively short follow-up period, SN-based de-escalating strategies, including perioperative MIB-PBI and RNI, demonstrated favorable oncological outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast Oncology, Tokyo-West Tokushukai Hospital, 3-1-1 Matsubara, Akishima, Tokyo 196-0003, Japan.
- Department of Radiation Oncology, Tokyo-West Tokushukai Hospital, 3-1-1 Matsubara, Akishima, Tokyo 196-0003, Japan.
ORCID-Profile: Kazuhiko Sato
Zitieren
APA
Sato, K., Fuchikami, H., Takeda, N., Natsume, N., & Kato, M. (2025). Sentinel node–guided radiotherapy in Japanese patients with early-stage breast cancer: a single-institution experience with partial-breast brachytherapy and regional nodal irradiation. Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyaf133
Vancouver
Sato K, Fuchikami H, Takeda N, Natsume N, Kato M. Sentinel node–guided radiotherapy in Japanese patients with early-stage breast cancer: a single-institution experience with partial-breast brachytherapy and regional nodal irradiation. Japanese Journal of Clinical Oncology. 2025. doi:10.1093/jjco/hyaf133
BibTeX
@article{Sato2025,
author = {Sato, Kazuhiko and Fuchikami, Hiromi and Takeda, Naoko and Natsume, Nana and Kato, Masahiro},
title = {Sentinel node–guided radiotherapy in Japanese patients with early-stage breast cancer: a single-institution experience with partial-breast brachytherapy and regional nodal irradiation},
journal = {Japanese Journal of Clinical Oncology},
year = {2025},
doi = {10.1093/jjco/hyaf133}
}
EUVIMED